Abrilada (Adalimumab-afzb)

Overview

Abrilada is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis and psoriatic arthritis, as well as rheumatoid arthritis, juvenile idiopathic… read more

Acthar Gel (Repository Corticotropin Injection)

Overview
Acthar Gel is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat conditions including multiple sclerosis, psoriatic arthritis, rheumatoid arthritis, and lupus. Acthar Gel is… read more

Amjevita (Adalimumab-atto)

Overview
Amjevita is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat active psoriatic arthritis and moderate to severe chronic plaque psoriasis in adults. Amjevita may be… read more

Bimzelx (Bimekizumab-Bkzx)

Bimzelx (bimekizumab-bkzx) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe psoriasis in…

Calcitrene (Calcipotriene)

Overview
Calcitrene is approved by the U.S. Food and Drug Administration (FDA) for the treatment of plaque psoriasis in adults. It is prescribed for individuals with mild to moderate plaque psoriasis and should not be…

Cimzia (Certolizumab Pegol) for Psoriasis

Cimzia (certolizumab pegol) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe plaque…

Cosentyx (Secukinumab) for Psoriasis

Cosentyx (secukinumab) is a biologic medicine approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe plaque psoriasis in…

Cyclosporine

Overview
Cyclosporine is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat psoriasis and rheumatoid arthritis and prevent the rejection of transplanted organs. Cyclosporine is sold… read more

Dovonex (Calcipotriene)

Overview
Dovonex is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis. Dovonex is also known by its drug name calcipotriene.

Calcipotriene, the active… read more

Duobrii (Halobetasol propionate/Tazarotene)

Overview
Duobrii is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis in people ages 18 and older. Duobrii is a combination drug composed of halobetasol propionate and… read more

Enbrel (Etanercept) for Psoriasis

Enbrel (etanercept) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe psoriasis in adults…

Erelzi (Etanercept-szzs)

Overview
Erelzi is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat psoriatic arthritis and moderate to severe chronic plaque psoriasis in adults. Erelzi may be referred to by… read more

Hadlima (Adalimumab-bwwd)

Overview
Hadlima is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe plaque psoriasis and active psoriatic arthritis. Hadlima is also known by its drug… read more

Hulio (Adalimumab-fkjp)

Overview
Hulio is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe plaque psoriasis and active psoriatic arthritis. Hulio is also referred to by its… read more

Humira (Adalimumab)

Humira (adalimumab) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe psoriasis in adults. 

Hyrimoz (Adalimumab-adaz)

Overview
Hyrimoz is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe plaque psoriasis and active psoriatic arthritis. Hyrimoz is also approved to treat… read more

Icotyde (Icotrokinra) for Psoriasis

Icotyde (icotrokinra) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults and children aged 12 years and older with moderate to severe…

Ilumya (Tildrakizumab-asmn)

Overview
Ilumya is approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe plaque psoriasis in cases where systemic therapy or phototherapy are warranted. Ilumya is also referred… read more

Imuldosa (Ustekinumab-Srlf)

Overview
Imuldosa is approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe plaque psoriasis in people ages 6 years and older who are candidates for phototherapy (light therapy) or…

Inflectra (Infliximab-dyyb)

Overview
Inflectra is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of active psoriatic arthritis and chronic severe plaque psoriasis. In cases of plaque psoriasis,… read more

Ixifi (Infliximab-qbtx)

Overview
Ixifi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with plaque psoriasis and psoriatic arthritis. Ixifi is also referred to by its drug name, infliximab-qbtx.… read more

Mobic (Meloxicam)

The Mobic brand name has been discontinued in the U.S. for reasons unrelated to safety or effectiveness. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to… read more

Neoral (Cyclosporine)

Overview
Neoral is a prescription medication originally approved by the U.S. Food and Drug Administration (FDA) in 1983. Neoral is approved to treat severe psoriasis in adults who do not respond to other treatments.… read more

Orencia (Abatacept)

Overview
Orencia is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat active psoriatic arthritis in adults. Orencia may be referred to by its drug name, abatacept.

Orencia is… read more

Otezla (Apremilast)

Otezla (apremilast) is an oral medication called a phosphodiesterase 4 (PDE4) inhibitor, approved by the U.S. Food and Drug Administration (FDA) for…

Otrexup (Methotrexate)

The Otrexup brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your…

Otulfi (Ustekinumab-Aauz)

Overview
Otulfi is approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe plaque psoriasis ages 6 years and older who are candidates for phototherapy (light therapy) or systemic therapy…

Pyzchiva (Ustekinumab-Ttwe)

Overview
Pyzchiva is approved by the U.S. Food and Drug Administration (FDA) for treating psoriasis. It is indicated for adults and children 6 and up who have moderate to severe plaque psoriasis or active psoriatic…

Rasuvo (Methotrexate)

Overview
Rasuvo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control the symptoms of severe, disabling psoriasis that is resistant to treatment. Rasuvo may be prescribed in adult… read more

Remicade (Infliximab)

Overview
Remicade is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of psoriatic arthritis and for chronic severe plaque psoriasis in people who are candidates for… read more

Renflexis (Infliximab-abda)

Overview
Renflexis is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat active psoriatic arthritis and chronic severe plaque psoriasis in people who are candidates for systemic… read more

Rinvoq (Upadacitinib)

Overview

Rinvoq is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with active psoriatic arthritis who either cannot tolerate or who have not had a sufficient response to a type…

Selarsdi (Ustekinumab-Aekn)

Overview
Selarsdi is approved by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe plaque psoriasis (PsO) in adults and children ages 6 and up who are candidates for phototherapy or…

Siliq (Brodalumab)

Overview
Siliq is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe psoriasis in adults. Siliq may be prescribed in cases where systemic therapy and phototherapy are… read more

Simlandi (Adalimumab-Ryvk)

Overview
Simlandi is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, as well as…

Simponi (Golimumab)

Overview
Simponi is approved by the U.S. Food and Drug Administration (FDA) to treat adults with active psoriatic arthritis. Simponi is also referred to by its drug name, golimumab. Golimumab is also sold under the… read more

Simponi Aria (Golimumab)

Overview
Simponi Aria is approved by the U.S. Food and Drug Administration (FDA) to treat adults and children over age 2 with active psoriatic arthritis. Simponi Aria is also referred to by its drug name, golimumab.… read more

Skyrizi (Risankizumab-Rzaa) for Psoriasis

Skyrizi (risankizumab-rzaa) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for adults with moderate to severe psoriasis…

Soriatane (Acitretin)

Overview
Soriatane is a prescription medication approved by the U.S. Food and Drug Administration (FDA) in 1996 for the treatment of severe psoriasis in adults. Soriatane is prescribed for all types of psoriasis.… read more

Sorilux (Calcipotriene)

Overview
Sorilux is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis of the scalp and body in adults. Sorilux is also known by its drug name, calcipotriene.… read more

Sotyktu (Deucravacitinib) for Psoriasis

Overview
Sotyktu is approved by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy, and for the treatment…

Spevigo (Spesolimab-Sbzo)

Overview
Spevigo is approved by the U.S. Food and Drug Administration (FDA) for treating generalized pustular psoriasis (GPP) in adults and children 12 years and older who weigh at least 40 kilograms (around 88 pounds)…

Stelara (Ustekinumab) for Psoriasis

Stelara (ustekinumab) is a medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe plaque psoriasis in adults…

Steqeyma (Ustekinumab-Stba)

Overview
Steqeyma is approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe plaque psoriasis in adults and children ages 6 years and older who are candidates for phototherapy (light…

Taclonex (Betamethasone/Calcipotriene)

Overview
Taclonex is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat psoriasis vulgaris in people ages 18 and older. Taclonex can be used to treat psoriasis on the scalp and nails in… read more

Taltz (Ixekizumab) for Psoriasis

Taltz (ixekizumab) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe plaque psoriasis in…

Tazorac (Tazarotene)

Overview
Tazorac is a prescription medication approved by the U.S. Food and Drug Administration (FDA) in 1997. Tazorac is used to treat stable plaque psoriasis in cases where it affects as much as 20 percent of the body… read more

Tremfya (Guselkumab) for Psoriasis

Tremfya (guselkumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe plaque psoriasis…

Trexall (Methotrexate)

Overview
Trexall is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat severe psoriasis. Trexall is also known by its drug name, methotrexate. Trexall may be prescribed along with… read more

Vectical (Calcitriol)

Overview
Vectical is a prescription medication approved by the U.S. Food and Drug Administration (FDA) in 2009. Vectical is used to treat mild to moderate plaque psoriasis in adults 18 years and older. Vectical is also… read more

Vtama (Tapinarof Cream)

Overview
Vtama cream is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis in adults. Vtama cream is also known by its drug name, tapinarof.

Vtama cream is… read more

Wynzora (Calcipotriene and Betamethasone dipropionate)

Overview
Wynzora is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis in people ages 18 and older. Wynzora is a combination drug composed of Calcipotriene and… read more

Xeljanz (Tofacitinib)

Overview
Xeljanz is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat active psoriatic arthritis in adults. Xeljanz may be prescribed in cases where psoriatic arthritis has not… read more

Yesintek (Ustekinumab-Kfce)

Overview
Yesintek is approved by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis. It is indicated for adults and children 6 and older who…

Zithranol-RR (Anthralin)

The Zithranol-RR brand name has been discontinued in the U.S. Other brand names or generic anthralin products may be available. If you’re currently using this type of medication, talk to your healthcare provider about… read more

Zoryve (Roflumilast)

Overview
Zoryve is approved by the U.S. Food and Drug Administration (FDA) for the treatment of plaque psoriasis of the scalp and body in adults and children 12 years of age and older. People with plaque psoriasis (a…